Silence Therapeutics PLC
OTC:SLNCF

Watchlist Manager
Silence Therapeutics PLC Logo
Silence Therapeutics PLC
OTC:SLNCF
Watchlist
Price: 5.79 USD 3.39%
Market Cap: 812.9m USD
Have any thoughts about
Silence Therapeutics PLC?
Write Note

Silence Therapeutics PLC
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Silence Therapeutics PLC
Net Income Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Silence Therapeutics PLC
OTC:SLNCF
Net Income
-ÂŁ22.9m
CAGR 3-Years
-30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Net Income
-$151.1m
CAGR 3-Years
-142%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Net Income
-$208.4m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Net Income
-$166.3m
CAGR 3-Years
-36%
CAGR 5-Years
-38%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Net Income
-ÂŁ55.3m
CAGR 3-Years
9%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Net Income
ÂŁ2.4m
CAGR 3-Years
-63%
CAGR 5-Years
-19%
CAGR 10-Years
-22%

See Also

What is Silence Therapeutics PLC's Net Income?
Net Income
-22.9m GBP

Based on the financial report for Dec 31, 2019, Silence Therapeutics PLC's Net Income amounts to -22.9m GBP.

What is Silence Therapeutics PLC's Net Income growth rate?
Net Income CAGR 3Y
-30%

Over the last year, the Net Income growth was -11%. The average annual Net Income growth rates for Silence Therapeutics PLC have been -30% over the past three years .

Back to Top